Assessment of the efficacy and safety of favipiravir in patients with SARS-CoV-2 infection in United Arab Emirates: A single-center study. Pharm Pract (Granada) [Internet]. 2024 May 31 [cited 2025 Oct. 22];22(2):1-8. Available from: https://www.pharmacypractice.org/index.php/pp/article/view/2917